CAR-T is an immune-cell therapy platform, whereas molecules such as CD19, CD22, CD33, and CD123 are the actual recognition targets. Beyond CAR-T, targeted leukemia research also covers aberrant kinases, oncogenic metabolites, apoptotic dependencies, transcriptional regulatory complexes, and ...
危险品化学品经营许可证（带存储）